Home
New scientific publication: ”Normative NeuroFlexor data for detection of spasticity after stroke: a cross-sectional study”
March 2016: The paper is availiable at JNER or PubMed.
NeuroFlexor mentioned in Lancet Neurology
October 2015: The paper is available through PubMed or at Lancet Neurology.
Testing the first prototype of the foot module
August 2015: The first version of the NeuroFlexor foot module is now being tested on adults with stroke. The device will soon be launched for research purposes.
New scientific publication
December 2014: Stubbs et al. recently published a clinical commentary on the NeuroFlexor in Novel Physiotherapies:
New submitted abstract
December 2014: Abstract submitted to ISB 2015, by Ruoli Wang et al: A Neuromusculosceletal model to simulate passive wrist extension test of spasticity.
New scientific publication
November 2014: A study on the use of NeuroFlexor in persons with Parkinson´s disease is available from the publisher´s website: Neural and Nonneural Contributions to Wrist Rigidity in Parkinson’s Disease: An Explorative Study Using the NeuroFlexor.
Meet us at TOXINS Nordic Congress in Copenhagen October 3-4 2014
Download our information brochure here.
Watch a video presentation here.
The NeuroFlexor is an objective measure of spasticity developed for clinical and research use. The NeuroFlexor separates mechanical and neuronal properties of the spastic muscle. It is a measurement instrument suitable for evaluation of rehabilitation interventions both in a clinical and a scientific setting. A common patient group is adults with stroke or traumatic brain injuries.
New scientific publication
June 2014: A study on the sensitivity to change of the NeuroFlexor is now available on PubMed: Sensitivity of the NeuroFlexor method to measure change in spasticity after treatment with botulinum toxin A in wrist and finger muscles.
CE-approval
March 2014: NeuroFlexor is now CE approved and is available for clinical use. Please review the EC Certificate found under Technical details.
Contact info@aggeromedtech.com for more information.